Pioglitazone Treatment Following Spinal Cord Injury Maintains Acute Mitochondrial Integrity and Increases Chronic Tissue Sparing and Functional Recovery

Pioglitazone is an FDA-approved PPAR-γ agonist drug used to for treat diabetes, and it has demonstrated neuroprotective effects in multiple models of central nervous system (CNS) injury. Acute treatment after spinal cord injury (SCI) in rats is reported to suppress neuroinflammation, rescue injured...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Exp Neurol
Main Authors: Patel, Samir P., Cox, David H., Gollihue, Jenna L., Bailey, William M., Geldenhuys, Werner J., Gensel, John C., Sullivan, Patrick G., Rabchevsky, Alexander G.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5473659/
https://ncbi.nlm.nih.gov/pubmed/28365473
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.expneurol.2017.03.021
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados